SEARCH

SEARCH BY CITATION

References

  • 1
    Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33: 657662.
  • 2
    Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994; 107: 532536.
  • 3
    Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CGM. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993; 17: 411417.
  • 4
    Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 1995; 108: 11591166.
  • 5
    Czaja AJ. Autoimmune hepatitis. Evolving concept and treatment strategies. Dig Dis Sci 1995; 40: 435456.
  • 6
    Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 1995; 90: 12061211.
  • 7
    Cassani F, Muratori L, Manotti P, Lenzi M, Fusconi M, Ballardini G, Selleri L, et al. Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection. Gut 1993; 33: 12601263.
  • 8
    Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U, Zauli D, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335: 258259.
  • 9
    Members of the Working Party of the World Congresses of Gastroenterology. Terminology of chronic hepatitis, hepatic allograft rejection and nodular lesions of the liver: summary of recommendations developed by an International Working Party, supported by the World Congresses of Gastroenterology, Los Angeles, CA, 1994. Am J Gastroenterol 1994; 89 (suppl): 8177181.
  • 10
    Bianchi FB, Cassani F, Lenzi M, Ballardini G, Muratori L, Giostra F, Zauli D. The impact of the International Autoimmune Hepatitis Group scoring system in the definition of autoimmune hepatitis: an Italian experience. Dig Dis Sci 1996; 41: 166171.
  • 11
    Johnson PJ, McFarlane IG, Convenors, on behalf of the panel. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 9981005.
  • 12
    Zauli D, Baffoni L, Cassani F, Fusconi M, Lenzi M, Ballardini G, Muratori L, et al. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis and autoimmune diseases. Gastroenterology 1992; 102: 10881089.
  • 13
    Muratori L, Cataleta M, Muratori P, Manotti P, Lenzi M, Cassani F, Bianchi FB. Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques. J Immunol Methods 1995; 187: 259264.
  • 14
    Fusconi M, Cassani F, Zauli D, Lenzi M, Ballardini G, Volta U, Bianchi FB. Anti-actin antibodies: a new test for an old problem. J Immunol Methods 1990; 130: 18.
  • 15
    Asakura H, Tsuchiya M, Aiso S, Watanabe M, Kobayashi K, Hibi T, Ando K, et al. Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis. Gastroenterology 1982; 82: 413418.
  • 16
    Sugimura K, Asakura H, Mizuki N, Inoue M, Hibi T, Yagita A, Tsuji K, et al. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol 1993; 36: 112118.
  • 17
    Wiik A, Stummann L, Kjeldsen L, Borregaard N, Ullman S, Jacobsen S, Halberg P. The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens. Clin Exp Immunol 1995; 101 (Suppl 1): 1517.
  • 18
    Wilschanski M, Chait P, Wade JA, Davis L, Corey M, Louis P St., Griffiths AM, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory and radiographic features, with survival analysis. Hepatology 1995; 22: 14141420.